Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2289 (LINC02289)

Target
LINC02289
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2289 (LINC02289) is a long intergenic non-protein coding RNA (lincRNA), meaning it is an autonomously transcribed RNA molecule longer than 200 nucleotides that does not overlap with protein-coding genes[1][5][7]. LINC02289 does not encode a protein and, as with the majority of lincRNAs, its specific biological functions have not been fully elucidated. Generally, lincRNAs are a subset of long non-coding RNAs that can perform regulatory roles, such as modulating chromatin structure, stabilizing RNAs, and regulating the transcription of coding or non-coding genes, sometimes via enhancer-like activities[3]. While some lincRNAs have been functionally implicated in cell proliferation, cell cycle regulation, chromatin modulation, or disease phenotypes, there is currently no evidence that LINC02289 serves as a therapeutic target, is directly associated with drugs, or acts as a biomarker for patient selection or efficacy monitoring[1][5][7].

Other names
LINC02289Long intergenic non-protein coding RNA 2289
02

Mechanism of action

Not applicable (no drugs known to directly target LINC02289)

03

Biological functions

Gene regulationChromatin remodelingTranscriptional regulationRNA stabilizationPotential enhancer-associated activityOther (functions for individual lincRNAs often remain to be clarified)
04

Disease associations

Other (LINC02289 itself has not yet been established as a prominent disease-associated molecule in published literature; broader lincRNA functions have been implicated in cancer and other diseases[3])
05

Safety considerations

None known (not a therapeutic target)
06

Interacting drugs

None known
07

Biomarkers

None known (LINC02289 is not an established biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2289 (LINC02289).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2289 (LINC02289).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call